The physical ability of elderly female Japanese patients with cerebrovascular disease correlates with telomere length in their peripheral blood leukocytes (original) (raw)

• McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000; 34: 331–58.
  Article CAS PubMed Google Scholar
• von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339–44.
  Article Google Scholar
• Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2003; 23: 842–6.
  Article CAS PubMed Google Scholar
• Ogami M, Ikura Y, Ohsawa M et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 2004; 24: 546–50.
  Article CAS PubMed Google Scholar
• Uziel O, Singer JA, Danicek V et al. Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control. Exp Gerontol 2007; 42: 971–8.
  Article CAS PubMed Google Scholar
• Panossian LA, Porter VR, Valenzuela HF et al. Telomere shortening in T cells correlates with Alzheimer’s disease status. Neurobiol Ageing. 2003; 24: 77–84.
  Article CAS Google Scholar
• Valdes AM, Andrew T, Gardner JP et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662–4.
  Article CAS PubMed Google Scholar
• Epel ES, Blackburn EH, Lin F et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004; 101: 17312–5.
  Article CAS PubMed Google Scholar
• Guan JZ, Maeda T, Sugano M et al. A Percentage analysis of the telomere length in Parkinson’s disease patients. J Gerontol A Biol Sci Med Sci 2008; 63A: 467–73.
  Article CAS Google Scholar
• Guan JZ, Maeda T, Sugano M, et al. An analysis of telomere length in sarcoidosis. J Gerontol A Biol Sci Med Sci 2007; 62: 1199–203.
  Article PubMed Google Scholar
• Cawthon RM, Smith KR, O’Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361: 393–5.
  Article CAS PubMed Google Scholar
• Guan JZ, Maeda T, Sugano M, Oyama J, Higuchi Y, Makino N. Change in the telomere length distribution with age in the Japanese population. Mol Cell Biochem 2007; 304: 253–60.
  Article Google Scholar
• Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14: 61–5.
  CAS PubMed Google Scholar
• Maeda T, Guan JZ, Oyama J, Higuchi Y, Makino N. Age-related changes in subtelomeric methylation in the normal Japanese population. J Gerontol A Biol Sci Med Sci 2009; 64: 426–34.
  Article PubMed Google Scholar
• Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis Circ Res 2007; 100: 460–73.
  Article CAS PubMed Google Scholar
• Kyo S, Takakura M, Kanaya T et al. Estrogen activates telomerase. Cancer Res 1999; 59: 5917–21.
  CAS PubMed Google Scholar
• Chao HH, Chen JJ, Chen CH et al. Inhibition of angiotensin II induced endothelin-1 gene expression by 17oestradiol in rat cardiac fibroblasts. Heart 2005; 91: 664–9.
  Article CAS PubMed Google Scholar
• Dantas AP, Tostes RC, Fortes ZB, Costa SG, Nigro D, Carvalho MH. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 2002; 39: 405–11.
  Article CAS PubMed Google Scholar
• Dean SA, Tan J, O’Brien ER, Leenen FH. 17-Estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am J Physiol Regul Integr Comp Physiol 2005; 288: R759–66.
  Article Google Scholar
• Florian M, Freiman A, Magder S. Treatment with 17-beta-estradiol reduces superoxide production in aorta of ovariectomized rats. Steroids 2004; 69: 779–87.
  Article CAS PubMed Google Scholar
• Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST. Estrogen reduces angiotensin II-induced nitric oxide synthase and NADPH oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: 38–44.
  Article CAS PubMed Google Scholar
• Laufs U, Adam O, Strehlow K et al. Down-regulation of Rac-1 GTPase by estrogen. J Biol Chem 2003; 95: 5956–62.
  Article Google Scholar
• Strehlow K, Rotter S, Wassmann S et al. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003; 93: 170–7.
  Article CAS PubMed Google Scholar
• Wagner AH, Schroeter MR, Hecker M. 17-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 2001; 15: 2121–30.
  Article CAS PubMed Google Scholar
• Wassmann S, Baumer AT, Strehlow K et al. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 2001; 103: 435–41.
  Article CAS PubMed Google Scholar
• Tang M, Subbiah MTR. Estrogens protect against hydrogen peroxide and arachidonic acid induced DNA damage. Biochim Biophys Acta 1996; 1299: 155–9.
  Article PubMed Google Scholar
• Hernandez-Ono A, Monter-Carreola G, Zamora-Gonzalez J et al. Association of visceral fat with coronary risk factors in a population- based sample of postmenopausal women. Int J Obes Relat Metab Disord 2002; 26: 33–9.
  Article CAS PubMed Google Scholar
• You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 2004; 89: 5517–22.
  Article CAS PubMed Google Scholar
• Tchernof A, Poehlman ET. Effects of the menopause transition on body fatness and body fat distribution. Obes Res 1998; 6: 246–54.
  Article CAS PubMed Google Scholar
• Faria AN, Ribeiro Filho FF, Gouveia Ferreira SR, Zanella MT. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women. Obes Res 2002; 10: 1203–6.
  Article PubMed Google Scholar
• Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC. The effects of the menopause transition on insulin sensitivity secretion and elimination in non-obese healthy women. Eur J Clin Invest 1993; 23: 466–73.
  Article CAS PubMed Google Scholar
• Witteman J, Grobbee D, Kok FJ, Hofman A, Valkenburg HA. Increased risk of atherosclerosis in women after menopause. BMJ 1989; 298: 642–4.
  Article CAS PubMed Google Scholar
• Yasumizu T, Okuno T, Fukada Y, Hoshi K. Age-related changes in bone mineral density and serum bone-related proteins in premenopausal and postmenopausal Japanese women. Endocr J 2000; 47: 103–9.
  Article CAS PubMed Google Scholar
• Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–37.
  Article CAS PubMed Google Scholar
• Sowers MR, La Pietra MT. Menopause: its epidemiology and potential association with chronic diseases. Epidemiol Rev 1995; 17: 287–302.
  CAS PubMed Google Scholar
• Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 1984; 63: 759–63.
  CAS PubMed Google Scholar
• Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178–208.
  CAS PubMed Google Scholar
• Valdes AM, Richards JB, Gardner JP et al. Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos Int 2007; 18: 1203–10.
  Article CAS PubMed Google Scholar